New daily pill could simplify tough bone infection treatment
NCT ID NCT05753215
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new antibiotic called omadacycline, taken once a day by mouth, against standard antibiotics for bone and joint infections. About 180 adults with these infections will be randomly assigned to receive either omadacycline or the usual care. The goal is to see if omadacycline works just as well and is easier for patients to stick with.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE AND JOINT INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Lundquist Institute For Biomedical Innovation at Harbor-UCLA Medical Center
Torrance, California, 90502, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A quick test for septic arthritis in kids — could it save joints?
- Emergency room study aims to improve diagnosis of septic arthritis
- Virus cocktail takes on superbug in Last-Resort hip infection trial
- Antibiotic side effects under the microscope in bone infection study
- Bone-Delivered antibiotics could spare joint infection patients from repeat surgeries
- Knee infection breakthrough? one surgery may replace two